Reaction #2329010

ord-0171bb6dfd914455bd397d0af991b7a6

Solvents

Conditions

Temperature
5°CELSIUS
Detailed conditions
See reaction.notes.procedure_details.

Workup

  1. 1
    Othervial fitted with a septa
  2. 2
    Othercap
  3. 3
    workup.STIRRINGThe reaction was stirred at 5° C. for 3 h
  4. 4
    Temperatureto warm to room temperature
  5. 5
    workup.STIRRINGstirred overnight at room temperature
  6. 6
    TemperatureThe reaction mixture was cooled to 0° C.
  7. 7
    Otherquenched with 2 mL of water
  8. 8
    workup.ADDITIONdiluted with 2 mL of methyl tert-butyl ether
  9. 9
    workup.STIRRINGThe vial was shaken vigourously
  10. 10
    Otherto separate
  11. 11
    OtherThe aqueous layer was removed with a pipette
  12. 12
    Washthe organic layer washed with another 2 mL of water
  13. 13
    DryingThe organic phase was dried (MgSO4)
  14. 14
    Concentrationconcentrated in vacuo
  15. 15
    Otherthe residue purified by reverse phase HPLC (Shimadzu)

Procedure

A 1.0 M solution of potassium t-butoxide in t-butanol (0.3 mL) was added to a 8 mL vial fitted with a septa cap containing 0.3 mL of dry THF and 30 mg (0.3 mmoles) of 3-hydroxy cylcopentanol at 5° C. The mixture was stirred for 0.5 h at 5° C., after which time 0.3 mL of a 1.0 M THF solution of 4-fluoro-2-chloro-benzonitrile was added. The reaction was stirred at 5° C. for 3 h and then allowed to warm to room temperature and stirred overnight at room temperature. The reaction mixture was cooled to 0° C., and quenched with 2 mL of water, diluted with 2 mL of methyl tert-butyl ether. The vial was shaken vigourously and the phases allowed to separate. The aqueous layer was removed with a pipette, and the organic layer washed with another 2 mL of water. The organic phase was dried (MgSO4), concentrated in vacuo, and the residue purified by reverse phase HPLC (Shimadzu) to give 36 mg (52%) of the title compound. GC/MS: 235 (M/Z for C13H14ClNO).

Source

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07670613B2uspto-grants-2010_03